About the firm
Founded in 2008
Twenty years of relationships
The Sieber Group is a boutique executive search firm serving the biotech and pharmaceutical commercial community. Small by design, so the attention never is.
Founder
Matt Sieber
Matt founded The Sieber Group in 2008, after leading recruitment for a global search firm. He has spent more than twenty years in the same corner of this industry: the commercial teams behind rare disease, oncology, orphan and biologic therapies.
Most of his work is with startup and mid-size organizations, often building a commercial team for the first or second time. That focus is the asset. When a client describes a role, he usually knows who's doing that job well right now, and whether they'd be open to a conversation.
Matt stays personally involved in every search, from intake through onboarding. That is why we are selective about the work we take on, and why no client gets handed down to someone still learning the market.
In their words
Trust that carries from company to company
Clients who've worked with Matt more than once tend to say the same thing.
I have worked with Matt Sieber at two different companies over the past 6 years, and I can honestly say that he is the best recruiter that I have ever worked with. When I see a resume from Matt Sieber, I know that I will be dealing with a quality candidate. I have hired more sales professionals from him over my career than any other source.
Matt S.Chief Commercial Officer
How we operate
Three commitments we don't flex on
We turn down searches
If a role sits outside what we know, or the expectations don't match the market, we'll say so rather than take the assignment and hope. That answer has started as many client relationships as it's ended.
Candidates are treated like clients
Everyone who talks to us is someone a hiring manager will want to meet in five years. Responsiveness and honesty aren't a courtesy. They're how the network stays worth having.
The relationship outlives the placement
Repeat business is the metric we watch. Clients who call us for their next search, and candidates who call us when they're building a team, are the entire business model.
Where we focus
Complex therapies, complex channels
Oncology, rare disease and orphan, specialty and biologics, hospital and IDN, buy and bill. Different science, but the same commercial problem: a complex reimbursement path, a narrow set of treating institutions, and a team that has to be excellent because it can't be large.
That's the environment we've worked in for two decades: pre-launch companies making their first commercial hires, mid-size biotechs scaling a field team, and established organizations replacing a critical seat without disrupting the market. Nationwide, from individual contributor through Director, Executive Director and VP level.
Get in touch
Start a conversation
Hiring, exploring, or just want a read on the market. All three are worth an email.